Literature DB >> 35257260

Novel mutation of EPM2A causes progressive myoclonic epilepsy: a case report.

Tao Liang1, Jing Wu2, Hongxing Chen1, Jun Qian1, Zhongxiang Xu3.   

Abstract

We report a case of progressive myoclonic epilepsy caused by a novel mutation in EPM2A. The female patient experienced abnormal jerky movements of the involving all four limbs and several generalized seizures, degeneration of cognition, and unsteadiness. Genetic analysis identified two rare, deleterious mutations in exon4: chr6: 145,948,751(c.G797G > A) and chr6: 145,948,761(c.T787C > T). The mutations at these two loci were from the genomes of their mother and father, respectively, which were compound heterozygous variations. This report updates the mutation sites of gene EPM2A and extends genotype-phenotype correlations in Lafora disease.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Case; EPM2A; Epilepsy; Lafora disease; Seizure

Mesh:

Substances:

Year:  2022        PMID: 35257260     DOI: 10.1007/s10072-022-05986-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  19 in total

Review 1.  Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects.

Authors:  Amre Shahwan; Michael Farrell; Norman Delanty
Journal:  Lancet Neurol       Date:  2005-04       Impact factor: 44.182

Review 2.  Lafora disease offers a unique window into neuronal glycogen metabolism.

Authors:  Matthew S Gentry; Joan J Guinovart; Berge A Minassian; Peter J Roach; Jose M Serratosa
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

Review 3.  Lafora disease.

Authors:  Julie Turnbull; Erica Tiberia; Pasquale Striano; Pierre Genton; Stirling Carpenter; Cameron A Ackerley; Berge A Minassian
Journal:  Epileptic Disord       Date:  2016-09-01       Impact factor: 1.819

Review 4.  Lafora's disease: towards a clinical, pathologic, and molecular synthesis.

Authors:  B A Minassian
Journal:  Pediatr Neurol       Date:  2001-07       Impact factor: 3.372

5.  Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.

Authors:  Madushi Raththagala; M Kathryn Brewer; Matthew W Parker; Amanda R Sherwood; Brian K Wong; Simon Hsu; Travis M Bridges; Bradley C Paasch; Lance M Hellman; Satrio Husodo; David A Meekins; Adam O Taylor; Benjamin D Turner; Kyle D Auger; Vikas V Dukhande; Srinivas Chakravarthy; Pascual Sanz; Virgil L Woods; Sheng Li; Craig W Vander Kooi; Matthew S Gentry
Journal:  Mol Cell       Date:  2014-12-24       Impact factor: 17.970

Review 6.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

7.  Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations.

Authors:  Antonella Riva; Alessandro Orsini; Marcello Scala; Vittoria Taramasso; Laura Canafoglia; Giuseppe d'Orsi; Maria Teresa Di Claudio; Carlo Avolio; Alfredo D'Aniello; Maurizio Elia; Silvana Franceschetti; Giancarlo Di Gennaro; Francesca Bisulli; Paolo Tinuper; Maria Tappatà; Antonino Romeo; Elena Freri; Carla Marini; Cinzia Costa; Vito Sofia; Edoardo Ferlazzo; Adriana Magaudda; Pierangelo Veggiotti; Elena Gennaro; Angela Pistorio; Carlo Minetti; Amedeo Bianchi; Salvatore Striano; Roberto Michelucci; Federico Zara; Berge Arakel Minassian; Pasquale Striano
Journal:  J Neurol Sci       Date:  2021-03-20       Impact factor: 3.181

8.  Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis.

Authors:  Luca Vignatelli; Francesca Bisulli; Federica Pondrelli; Lorenzo Muccioli; Laura Licchetta; Barbara Mostacci; Corrado Zenesini; Paolo Tinuper
Journal:  Orphanet J Rare Dis       Date:  2021-08-16       Impact factor: 4.123

9.  Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.

Authors:  Felix Nitschke; Mitchell A Sullivan; Peixiang Wang; Xiaochu Zhao; Erin E Chown; Ami M Perri; Lori Israelian; Lucia Juana-López; Paola Bovolenta; Santiago Rodríguez de Córdoba; Martin Steup; Berge A Minassian
Journal:  EMBO Mol Med       Date:  2017-07       Impact factor: 12.137

Review 10.  Genetics of Lafora progressive myoclonic epilepsy: current perspectives.

Authors:  Miljana Kecmanović; Milica Keckarević-Marković; Dušan Keckarević; Galina Stevanović; Nebojša Jović; Stanka Romac
Journal:  Appl Clin Genet       Date:  2016-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.